Home Menu

Site Navigation



Parkinson's Disease Tulip

NeuroTalk Support Groups > > >

New pharmacokinetics and biomarker data from the Georgetown Nilotinib trial

Reply
 
Thread Tools Display Modes
Old 03-13-2019, 01:47 PM #1
Tupelo3 Tupelo3 is offline
Member
  
Join Date: Mar 2013
Location: New Jersey
Posts: 832
10 yr Member
Tupelo3 Tupelo3 is offline
Member
 
Join Date: Mar 2013
Location: New Jersey
Posts: 832
10 yr Member
Default New pharmacokinetics and biomarker data from the Georgetown Nilotinib trial
Georgetown released some new pharmacokinetics and other biomarker data in a new report. Keep in mind it was just signal dose on small sample. I didn’t see anything groundbreaking here.

BPS Publications
Tupelo3 is offline   Reply With QuoteReply With Quote
"Thanks for this!" says:
Betsy859 (04-23-2019), eds195 (03-14-2019), jeffreyn (03-13-2019), lab rat (03-15-2019), soccertese (03-16-2019)
Old 03-14-2019, 09:49 AM #2
ashleyk ashleyk is offline
Member
  
Join Date: Oct 2006
Location: New England
Posts: 262
15 yr Member
ashleyk ashleyk is offline
Member
 
Join Date: Oct 2006
Location: New England
Posts: 262
15 yr Member
Default ?
I did a quick read on this. Did I miss anything on patient symptoms improving?
ashleyk is offline   Reply With QuoteReply With Quote
Old 03-14-2019, 02:06 PM #3
Tupelo3 Tupelo3 is offline
Member
  
Join Date: Mar 2013
Location: New Jersey
Posts: 832
10 yr Member
Tupelo3 Tupelo3 is offline
Member
 
Join Date: Mar 2013
Location: New Jersey
Posts: 832
10 yr Member
Default
Quote:
Originally Posted by ashleyk View Post
I did a quick read on this. Did I miss anything on patient symptoms improving?
This was just pharmacokinetics and biomarker data analysis. We’re all still waiting for primary and secondary objective results which would give indications about efficacy. Some of the reported results in this article were very strange.
Tupelo3 is offline   Reply With QuoteReply With Quote
"Thanks for this!" says:
Betsy859 (04-23-2019), zanpar321 (03-15-2019)
Old 03-14-2019, 10:29 AM #4
zanpar321 zanpar321 is offline
Member
  
Join Date: Feb 2014
Posts: 365
10 yr Member
zanpar321 zanpar321 is offline
Member
 
Join Date: Feb 2014
Posts: 365
10 yr Member
Default
Quote:
Originally Posted by Tupelo3 View Post
Georgetown released some new pharmacokinetics and other biomarker data in a new report. Keep in mind it was just signal dose on small sample. I didn’t see anything groundbreaking here.

BPS Publications
Some more data but what a waste of a study. I can't see how much can be learned from a single dose. No discussion of how this moved any up the road to approval/validation as a useful drug.
zanpar321 is offline   Reply With QuoteReply With Quote
Reply

Tags
biomarker, data, georgetown, pharmacokinetics, sample

« Previous Thread | Next Thread »

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts
BB code is On
Smilies are On
[IMG] code is On
HTML code is Off

Similar Threads
Thread Thread Starter Forum Replies Last Post
Recruitment has begun for the Georgetown University "PD Nilotinib" phase 2 trial jeffreyn Parkinson's Disease 3 02-26-2017 07:05 PM
Georgetown Clinical Trial of Nilotinib in Alzheimer’s Disease Begins Tupelo3 Parkinson's Disease 0 01-24-2017 01:11 PM
Impact of Nilotinib on Safety, Tolerability, Pharmacokinetics and Biomarkers in Parki badboy99 Parkinson's Disease 1 11-05-2016 02:02 AM
Georgetown Receives FDA Clearance for Trial with Nilotinib in Alzheim zanpar321 Parkinson's Disease 10 10-07-2016 08:46 PM
Six month follow up on Nilotinib trial. Betsy859 Parkinson's Disease 30 07-17-2016 05:52 PM


All times are GMT -5. The time now is 07:31 AM.


Powered by vBulletin • Copyright ©2000 - 2025, Jelsoft Enterprises Ltd.

vBulletin Optimisation provided by vB Optimise (Lite) - vBulletin Mods & Addons Copyright © 2025 DragonByte Technologies Ltd.
 

NeuroTalk Forums

Helping support those with neurological and related conditions.

 

All posts copyright their original authors.

The material on this site is for informational purposes only,
and is not a substitute for medical advice, diagnosis or treatment
provided by a qualified health care provider.

Always consult your doctor before trying anything you read here.

Home